Case number 1:19-cv-00120
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 22 | Motion to Amend/Correct (3) |
| Jul 9, 2020 | 19 | Motion to Amend/Correct (3) |
| Jul 9, 2020 | 16 | Motion to Amend/Correct (4) |
| Jul 9, 2020 | 14 | Motion for Extension of Time to File (4) |
| Jul 9, 2020 | 7 | Motion for Leave to Appear (2) |
| Jan 13, 2020 | 30 | Report Re: Patent/Trademark (1) Docket Text: AMENDED REPORT to USPTO on the filing or determination of an action regarding re [29] Order. (dk) |
| Jan 13, 2020 | 29 | Order (3) Docket Text: NOTICE AND AMENDED ORDER OF DISMISSAL, without prejudice. Signed by Senior Judge Irene M. Keeley on 1/13/2020. (dk) |
| Jan 9, 2020 | 26 | Other Document (3) Docket Text:Notice and [Proposed] Order of Dismissal Other Document filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Companion, James) |
| Jan 9, 2020 | 28 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [27] Order Dismissing Case. (dk) |
| Jan 9, 2020 | 27 | Order Dismissing Case (3) Docket Text: NOTICE AND ORDER OF DISMISSAL without prejudice. Signed by Senior Judge Irene M. Keeley on 1/9/2020. (dk) |
| Jan 7, 2020 | 25 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Sandra K. Law on behalf of All Plaintiffs (Law, Sandra) |
| Jan 7, 2020 | 21 | Stipulation (3) Docket Text: STIPULATION EXTENDING DEFENDANT'S DEADLINE TO ANSWER COMPLAINT by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Jan 7, 2020 | 22 | Main Document (3) Docket Text: Joint MOTION to Amend/Correct Planning Dates by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Jan 7, 2020 | 22 | Proposed Order (1) |
| Jan 7, 2020 | 23 | Order on Motion to Amend/Correct (1) Docket Text: WRONG EVENT USED (Main Document 23 replaced on 1/7/2020 NEF Regenerated (jmm). Modified on 1/8/2020 to correct language in docket text(jmm). |
| Jan 7, 2020 | 24 | Order on Motion to Amend/Correct (1) Docket Text: ORDER GRANTING MOTION [DKT. NO. 22] AND AMENDED PLANNING CONFERENCE AND RELATED DATES. Defendants Answer due by February 10, 2020. Rule 26 Meeting to be held by 2/24/2020. Rule 26 Meeting Report due by 3/3/2020. Scheduling Conference set for 3/11/2020 02:00 PM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley. Discovery due by 3/23/2020. Signed by Senior Judge Irene M. Keeley on 1/7/2020. (copy counsel of record)(jmm) |
| Nov 27, 2019 | 19 | Main Document (3) Docket Text: Joint MOTION to Amend/Correct Planning Dates (Third) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Nov 27, 2019 | 19 | Proposed Order (1) |
| Nov 27, 2019 | 20 | Order on Motion to Amend/Correct (1) Docket Text: ORDER AMENDING PLANNING CONFERENCE AND RELATED DATES granting [19] Motion to Amend/Correct. Defendant's Answer due 1/10/2020. Rule 26 Meeting to be held by 1/23/2020. Rule 26 Meeting Report due by 2/3/2020. Scheduling Conference set for 2/12/2020 01:00 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 2/21/2020. Signed by Senior Judge Irene M. Keeley on 11/27/2019. (dk) |
| Nov 27, 2019 | 18 | Stipulation (3) Docket Text: STIPULATION EXTENDING DEFENDANT'S DEADLINE TO ANSWER COMPLAINT by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Nov 4, 2019 | 17 | Order on Motion to Amend/Correct (1) Docket Text: ORDER AMENDING PLANNING CONFERENCE AND RELATED DATES granting [16] Motion to Amend/Correct. Defendant's Answer due 12/6/19; Rule 26 Meeting to be held by 12/19/2019; Rule 26 Meeting Report due by 12/30/2019; Scheduling Conference set for 1/10/2020 01:00 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley; Discovery due by 1/17/2020. Signed by Senior Judge Irene M. Keeley on 11/4/19. (mh) |
| Nov 1, 2019 | 16 | Text of Proposed Order (1) |
| Nov 1, 2019 | 16 | Main Document (4) Docket Text: Joint MOTION to Amend/Correct Planning Dates by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(O'Brien, William) |
| Oct 8, 2019 | 15 | Order on Motion for Extension of Time to File (1) Docket Text: ORDER AMENDING PLANNING CONFERENCE AND RELATED DATES granting [14] Motion for Extension of Time to File. Rule 26 Meeting to be held by 11/18/2019. Rule 26 Meeting Report due by 12/2/2019. Scheduling Conference set for 12/17/2019 12:15 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 12/20/2019. Defendant's Answer due on 11/5/19. Signed by Senior Judge Irene M. Keeley on 10/8/19. (mh) |
| Oct 7, 2019 | 14 | Text of Proposed Order (1) |
| Oct 7, 2019 | 14 | Main Document (4) Docket Text: Joint MOTION for Extension of Time to File Planning order documents and events by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Copland, Gordon) |
| Sep 4, 2019 | 13 | Stipulation (3) Docket Text: STIPULATION EXTENDING DEFENDANT'S DEADLINE TO ANSWER COMPLAINT by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Aug 27, 2019 | 12 | FirstOrder (3) Docket Text: FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 10/21/2019. Rule 26 Meeting Report due by 11/4/2019. Scheduling Conference set for 11/18/2019 02:30 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 11/25/2019. Signed by Senior Judge Irene M. Keeley on 8/27/2019. (jmm) |
| Aug 26, 2019 | 11 | Summons Returned Executed (3) Docket Text: SUMMONS Returned Executed (from Secretary of State) as to Mylan Pharmaceuticals Inc. served on 8/20/2019. (jmm) |
| Jun 11, 2019 | 7 | Text of Proposed Order (1) |
| Jun 11, 2019 | 9 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [7] Motion for Leave to Appear Pro Hac Vice for Attorney Nicholas N. Kallas. Signed by Senior Judge Irene M. Keeley on 6/11/2019. (jmm) |
| Jun 11, 2019 | 7 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
| Jun 6, 2019 | 1 | Complaint (11) |
| Jun 6, 2019 | 6 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION.(sent via email) (jmm) |
| Jun 6, 2019 | 5 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Novartis AG. (jmm) |
| Jun 6, 2019 | 4 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (jmm) |
| Jun 6, 2019 | 3 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (jmm) |
| Jun 6, 2019 | 1 | Main Document (11) Docket Text: COMPLAINT against Mylan Pharmaceuticals Inc., filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # (1) Exhibit A Patent Number 5,665,772, # (2) Exhibit B Patent Number US 8,778,962 B2, # (3) Exhibit C Patent No. US 8,436,010 B2, # (4) Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appliation (ANDA), # (5) Civil Cover Sheet)(jmm) |
| Jun 6, 2019 | 1 | Civil Cover Sheet (2) |
| Jun 6, 2019 | 1 | Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appl (2) |
| Jun 6, 2019 | 1 | Exhibit Patent No. US 8,436,010 B2 (11) |
| Jun 6, 2019 | 1 | Exhibit B Patent Number US 8,778,962 B2 (11) |
| Jun 6, 2019 | 1 | Exhibit A Patent Number 5,665,772 (16) |
| Jun 6, 2019 | 1 | Complaint* (1) |
